Savara Inc (SVRA)

↓ Download CSV

CIK 0001160308 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

Key ratios (FY2025)

-58.5%
Return on equity
Metric (FY)2025202420232022202120202019201820172016
Revenue$257.0K$0
Operating Income-$123.55M-$103.20M-$60.01M-$38.84M-$41.48M-$49.30M-$79.03M-$70.05M-$29.96M-$10.95M
Net Income-$118.84M-$95.88M-$54.70M-$38.15M-$43.01M-$49.62M-$78.17M-$61.52M-$29.80M-$10.92M
EPS (Diluted)$-0.53$-0.48$-0.33$-0.25$-0.32
Total Assets$253.44M$212.88M$177.56M$139.78M$176.60M$97.75M$136.20M$152.29M$159.63M$28.93M
Total Liabilities$50.30M$41.43M$37.19M$32.00M$32.10M$33.36M$34.51M$44.07M$40.32M$20.95M
Shareholders' Equity$203.13M$171.45M$140.37M$107.78M$144.50M$64.38M$101.70M$108.22M$119.31M-$35.88M
Cash & Equivalents$33.18M$15.13M$26.59M$52.10M$34.01M$22.88M$49.80M$24.30M$22.12M$13.37M
Operating Cash Flow-$101.04M-$89.09M-$51.06M-$34.55M-$40.08M-$39.84M-$45.12M-$39.27M-$28.23M
Capital Expenditures$22.0K$25.0K$296.0K$9.0K$57.0K$47.0K$148.0K$141.0K$495.0K$8.0K
Shares Outstanding204.57M172.42M138.14M114.05M114.04M54.15M50.79M35.15M30.51M3.16M